Item 1. Financial Statements
Item 1. Financial Statements
LEIDOS HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited; in millions, except share and per share data) April 4,
2025 January 3,
2025
Assets:
Cash and cash equivalents $ 842 $ 849
Receivables, net 2,906 2,645
Inventory, net 347 315
Other current assets 454 525
Total current assets 4,549 4,334
Property, plant and equipment, net 977 991
Intangible assets, net 489 517
Goodwill 6,098 6,084
Operating lease right-of-use assets, net 541 560
Other long-term assets 543 524
Total assets $ 13,197 $ 13,010
Liabilities:
Accounts payable and accrued liabilities $ 2,178 $ 2,131
Accrued payroll and employee benefits 664 811
Current portion of long-term debt 119 618
Total current liabilities 2,961 3,560
Long-term debt, net of current portion 5,014 4,052
Operating lease liabilities 603 621
Other long-term liabilities 317 317
Total liabilities 8,895 8,550
Commitments and contingencies (Note 11)
Stockholders’ equity:
Common stock, $ 0.0001 par value, 500,000,000 shares authorized, 128,715,893 and 131,163,899 shares issued and outstanding at April 4, 2025, and January 3, 2025, respectively
— —
Additional paid-in capital 619 1,112
Retained earnings 3,721 3,410
Accumulated other comprehensive loss ( 83 ) ( 110 )
Total Leidos stockholders’ equity 4,257 4,412
Non-controlling interest 45 48
Total stockholders' equity 4,302 4,460
Total liabilities and stockholders' equity $ 13,197 $ 13,010
See accompanying notes to condensed consolidated financial statements.
Leidos Holdings, Inc.
1
Table of Contents
PART I—FINANCIAL INFORMATION
LEIDOS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
(unaudited; in millions, except per share data) April 4,
2025 March 29,
2024
Revenues $ 4,245 $ 3,975
Cost of revenues 3,488 3,337
Selling, general and administrative expenses 230 226
Acquisition, integration and restructuring costs 4 4
Equity earnings of non-consolidated subsidiaries ( 7 ) ( 7 )
Operating income 530 415
Non-operating income (expense):
Interest expense, net ( 49 ) ( 49 )
Other (expense) income, net
( 3 ) 2
Income before income taxes 478 368
Income tax expense ( 113 ) ( 85 )
Net income 365 283
Less: net income (loss) attributable to
non-controlling interest
2 ( 1 )
Net income attributable to Leidos common stockholders $ 363 $ 284
Earnings per share:
Basic $ 2.79 $ 2.09
Diluted 2.77 2.07
See accompanying notes to condensed consolidated financial statements.
2
Leidos Holdings, Inc.
Table of Contents
PART I—FINANCIAL INFORMATION
LEIDOS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Three Months Ended
(unaudited; in millions) April 4,
2025 March 29,
2024
Net income $ 365 $ 283
Foreign currency translation adjustments
28 ( 27 )
Unrecognized (loss) gain on derivative instruments
( 1 ) 2
Pension adjustments — 1
Total other comprehensive income (loss), net of taxes 27 ( 24 )
Comprehensive income 392 259
Less: net income (loss) attributable to non-controlling interest
2 ( 1 )
Comprehensive income attributable to Leidos common stockholders
$ 390 $ 260
See accompanying notes to condensed consolidated financial statements.
Leidos Holdings, Inc.
3
Table of Contents
PART I—FINANCIAL INFORMATION
LEIDOS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(unaudited; in millions, except per share data) Shares of common stock Additional
paid-in
capital Retained earnings Accumulated
other comprehensive
income (loss) Leidos stockholders' equity Non-controlling interest Total stockholders' equity
Balance at January 3, 2025 131 $ 1,112 $ 3,410 $ ( 110 ) $ 4,412 $ 48 $ 4,460
Net income — — 363 — 363 2 365
Other comprehensive income, net of taxes — — — 27 27 — 27
Issuances of stock 1 17 — — 17 — 17
Repurchases of stock and other
( 3 ) ( 531 ) — — ( 531 ) — ( 531 )
Dividends of $ 0.40 per share
— ( 52 ) — ( 52 ) — ( 52 )
Stock-based compensation — 21 — — 21 — 21
Net capital distributions to non-controlling interest — — — — — ( 5 ) ( 5 )
Balance at April 4, 2025 129 $ 619 $ 3,721 $ ( 83 ) $ 4,257 $ 45 $ 4,302
(unaudited; in millions, except per share data) Shares of common stock Additional
paid-in
capital Retained earnings Accumulated
other comprehensive
income (loss) Leidos stockholders' equity Non-controlling interest Total stockholders' equity
Balance at December 29, 2023 136 $ 1,885 $ 2,364 $ ( 48 ) $ 4,201 $ 57 $ 4,258
Net income (loss) — — 284 — 284 ( 1 ) 283
Other comprehensive loss, net of taxes — — — ( 24 ) ( 24 ) — ( 24 )
Issuances of stock — 14 — — 14 — 14
Repurchases of stock and other
( 1 ) ( 184 ) — — ( 184 ) — ( 184 )
Dividends of $ 0.38 per share
— — ( 53 ) — ( 53 ) — ( 53 )
Stock-based compensation — 20 — — 20 — 20
Net capital distributions to non-controlling interest — — — — — ( 1 ) ( 1 )
Balance at March 29, 2024 135 $ 1,735 $ 2,595 $ ( 72 ) $ 4,258 $ 55 $ 4,313
See accompanying notes to condensed consolidated financial statements.
4
Leidos Holdings, Inc.
Table of Contents
PART I—FINANCIAL INFORMATION
LEIDOS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended
(unaudited; in millions) April 4,
2025 March 29,
2024
Cash flows from operations:
Net income $ 365 $ 283
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization 69 69
Stock-based compensation 21 20
Deferred income taxes ( 24 ) ( 25 )
Other ( 1 ) ( 6 )
Change in assets and liabilities
Receivables ( 246 ) ( 281 )
Other current assets and other long-term assets ( 27 ) ( 35 )
Accounts payable and accrued liabilities and other long-term liabilities ( 72 ) ( 51 )
Accrued payroll and employee benefits ( 148 ) 48
Income taxes receivable/payable 121 91
Net cash provided by operating activities 58 113
Cash flows from investing activities:
Payments for property, equipment and software ( 22 ) ( 17 )
Other — 5
Net cash used in investing activities ( 22 ) ( 12 )
Cash flows from financing activities:
Proceeds from debt issuance 997 —
Repayments of borrowings ( 529 ) ( 4 )
Payments for debt issuance costs ( 7 ) —
Dividend payments ( 53 ) ( 53 )
Repurchases of stock and other ( 528 ) ( 183 )
Proceeds from issuances of stock 15 13
Net capital distributions to non-controlling interests ( 5 ) ( 1 )
Net cash used in financing activities ( 110 ) ( 228 )
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash 7 ( 4 )
Net decrease in cash, cash equivalents and restricted cash
( 67 ) ( 131 )
Cash, cash equivalents and restricted cash at beginning of period 991 792
Cash, cash equivalents and restricted cash at end of period 924 661
Less: restricted cash at end of period 82 114
Cash and cash equivalents at end of period $ 842 $ 547
See accompanying notes to condensed consolidated financial statements.
Leidos Holdings, Inc.
5
Table of Contents
PART I—FINANCIAL INFORMATION
LEIDOS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [CONTINUED]
Three Months Ended
(unaudited; in millions) April 4,
2025 March 29,
2024
Supplementary cash flow information:
Cash paid for income taxes, net of refunds $ ( 4 ) $ 2
Cash paid for interest 51 61
Non-cash investing activity:
Property, plant and equipment additions
$ — $ 35
See accompanying notes to condensed consolidated financial statements.
6
Leidos Holdings, Inc.
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Note 1–Basis of Presentation and Summary of Significant Accounting Policies
NATURE OF OPERATIONS AND BASIS OF PRESENTATION
Leidos Holdings, Inc. ("Leidos"), a Delaware corporation, is a holding company whose direct 100 %-owned subsidiary and principal operating company is Leidos, Inc. Leidos, is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with 47,000 global employees, Leidos' customers include the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security, the Federal Aviation Administration, the Department of Veterans Affairs and many other U.S. civilian, state and local government agencies, foreign government agencies and commercial businesses. Unless indicated otherwise, references to "we," "us" and "our" refer collectively to Leidos Holdings, Inc. and its consolidated subsidiaries.
We have a controlling interest in Mission Support Alliance, LLC ("MSA"), a joint venture with Centerra Group, LLC. We also have a controlling interest in Hanford Mission Integration Solutions, LLC ("HMIS"), the legal entity for the follow-on contract to MSA's contract and a joint venture with Centerra Group, LLC and Parsons Government Services, Inc. The financial results for MSA and HMIS are consolidated into our unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements also include the balances of all voting interest entities in which Leidos has a controlling voting interest ("subsidiaries") and a variable interest entity ("VIE") in which Leidos is the primary beneficiary. The consolidated balances of the VIE are not material to the unaudited condensed consolidated financial statements for the periods presented. Intercompany accounts and transactions between consolidated companies have been eliminated in consolidation.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules of the U.S. Securities and Exchange Commission and accounting principles generally accepted in the United States of America ("GAAP"). Certain disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingencies at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management evaluates these estimates and assumptions on an ongoing basis, including those relating to estimated profitability of long-term contracts, indirect billing rates, allowances for doubtful accounts, inventories, right-of-use assets and lease liabilities, fair value and impairment of intangible assets and goodwill, income taxes, stock-based compensation expense and contingencies. These estimates have been prepared by management on the basis of the most current and best available information; however, actual results could differ materially from those estimates.
Certain amounts in the prior year financial statements have been reclassified to conform to the current year presentation. We changed our Cash and Cash Equivalents policy to exclude outstanding payments from “Cash and cash equivalents” on the condensed consolidated balance sheets. Prior year financial information has been updated to conform to our current presentation on the condensed consolidated balance sheet and condensed consolidated statement of cash flows. See the Cash and Cash Equivalents section below for further discussion of the change and the impact on the financial statements.
In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which consist of normal recurring adjustments, necessary for a fair presentation thereof. The results reported in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K filed on February 11, 2025.
Leidos Holdings, Inc.
7
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
ACCOUNTING STANDARDS UPDATES ISSUED BUT NOT YET ADOPTED
ASU 2023-09 Income Taxes
In December 2023, the FASB issued ASU 2023-09, to enhance the transparency and usefulness of income tax disclosures. The update requires enhancements to the annual rate reconciliation, including disclosure of specific categories and additional information for reconciling items meeting a quantitative threshold. The update also requires disclosure of income taxes paid disaggregated by federal, state and foreign taxes, and individual jurisdictions meeting a quantitative threshold.
The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. We are currently evaluating the impacts of this update and plan to adopt these amendments using the prospective approach for annual disclosures in fiscal 2025.
ASU 2024-03 Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, to enhance the transparency of certain expense disclosures. The update requires disclosure of specific expense categories in the notes to the financial statements at interim and annual reporting periods. The update requires disaggregated information about certain prescribed expense categories underlying any relevant income statement expense caption.
The amendments in this update are effective for public entities for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The amendments may be adopted either prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the impacts of this update and plan to adopt these amendments for annual disclosures in fiscal 2027 and interim disclosures in fiscal 2028.
CHANGES IN ESTIMATES ON CONTRACTS
Changes in estimates related to contracts accounted for using the cost-to-cost method of accounting are recognized in the period in which such changes are made for the inception-to-date effect of the changes, with the exception of contracts acquired through a business combination, where the adjustment is made for the period commencing from the date of acquisition.
Changes in estimates on contracts were as follows:
Three Months Ended
(in millions, except per share data) April 4,
2025 March 29,
2024
Favorable impact $ 53 $ 25
Unfavorable impact ( 23 ) ( 25 )
Net impact to income before income taxes $ 30 $ —
Impact on diluted EPS attributable to Leidos common stockholders
$ 0.17 $ —
The impact on diluted earnings per share ("EPS") attributable to Leidos common stockholders is calculated using the statutory tax rate.
Revenue Recognized from Prior Obligations
We recognized revenue of $ 27 million and reduced revenue by $ 2 million from performance obligations satisfied in previous periods for the three months ended April 4, 2025, and March 29, 2024, respectively. The changes primarily relate to revisions of variable consideration including award and incentive fees, and revisions to estimates at completion resulting from changes in contract scope, mitigation of contract risks or true-ups of contract estimates at the end of contract performance.
CASH AND CASH EQUIVALENTS
Our cash equivalents are primarily comprised of investments in several large institutional money market accounts, with original maturity of three months or less. Effective as of the first quarter of fiscal 2025, we changed our policy to exclude outstanding payments from “Cash and cash equivalents” on the condensed consolidated balance sheets. To reflect the change in accounting policy, we recast "Cash and cash equivalents" and "Accounts payable and accrued liabilities" on the condensed consolidated balance sheet as of of January 3, 2025, reducing both balances by $ 94 million from the previously
8
Leidos Holdings, Inc.
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
reported amounts. The recast of the condensed consolidated statement of cash flows for the three months ended March 29, 2024, resulted in an increase of $ 50 million to net cash provided by operations. Net cash provided by operations on the condensed consolidated statement of cash flows for the three months ended April 4, 2025, was not materially impacted by the change in accounting policy.
We believe this presentation enhances the usefulness of financial reporting and enhances comparability to align with industry practice. There is no impact to our condensed consolidated statements of operations, including EPS, condensed consolidated statements of comprehensive income, or condensed consolidated statements of equity. All periods presented have been adjusted.
RESTRICTED CASH
We have restricted cash balances, primarily representing advances from customers that are restricted for use on certain expenditures related to that customer's contract. Restricted cash balances are included as "Other current assets" in the condensed consolidated balance sheets. Our restricted cash balances were $ 82 million and $ 141 million at April 4, 2025, and January 3, 2025, respectively.
Note 2–Revenues
REMAINING PERFORMANCE OBLIGATIONS
Remaining performance obligations ("RPO") represent the expected value of exercised contracts, both funded and unfunded, less revenue recognized to date. RPO does not include unexercised option periods and future potential task orders expected to be awarded under indefinite delivery/indefinite quantity ("IDIQ") contracts, General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded and separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future anticipated task orders.
As of April 4, 2025, we had $ 17 billion of RPO and expect to recognize approximately 65 % and 81 % over the next 12 months and 24 months, respectively, with the remainder to be recognized thereafter.
DISAGGREGATION OF REVENUES
We disaggregate revenues by customer-type, contract-type and geographic location for each of our reportable segments.
Disaggregated revenues by customer-type were as follows:
Three Months Ended April 4, 2025
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
DoD and U.S. Intelligence Community
$ 1,326 $ 269 $ 10 $ 454 $ 2,059
Other U.S. government agencies (1)
516 999 97 24 1,636
Commercial and non-U.S. customers
25 18 460 30 533
Total $ 1,867 $ 1,286 $ 567 $ 508 $ 4,228
Three Months Ended March 29, 2024
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
DoD and U.S. Intelligence Community
$ 1,221 $ 257 $ 10 $ 425 $ 1,913
Other U.S. government agencies (1)
525 917 73 22 1,537
Commercial and non-U.S. customers
33 16 425 27 501
Total $ 1,779 $ 1,190 $ 508 $ 474 $ 3,951
(1) Includes federal government agencies other than the DoD and U.S. Intelligence Community, as well as state and local government agencies.
Leidos Holdings, Inc.
9
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Disaggregated revenues by contract-type were as follows:
Three Months Ended April 4, 2025
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
Cost-reimbursement and fixed-price-incentive-fee
$ 1,013 $ 471 $ 95 $ 309 $ 1,888
Firm-fixed-price 497 759 359 154 1,769
Time-and-materials and fixed-price-level-of-effort
357 56 113 45 571
Total $ 1,867 $ 1,286 $ 567 $ 508 $ 4,228
Three Months Ended March 29, 2024
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
Cost-reimbursement and fixed-price-incentive-fee
$ 946 $ 447 $ 85 $ 301 $ 1,779
Firm-fixed-price 492 690 319 139 1,640
Time-and-materials and fixed-price-level-of-effort
341 53 104 34 532
Total $ 1,779 $ 1,190 $ 508 $ 474 $ 3,951
Disaggregated revenues by geographic location were as follows:
Three Months Ended April 4, 2025
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
United States
$ 1,859 $ 1,285 $ 238 $ 499 $ 3,881
International
8 1 329 9 347
Total $ 1,867 $ 1,286 $ 567 $ 508 $ 4,228
Three Months Ended March 29, 2024
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
United States
$ 1,770 $ 1,189 $ 208 $ 468 $ 3,635
International
9 1 300 6 316
Total $ 1,779 $ 1,190 $ 508 $ 474 $ 3,951
Revenues by customer-type, contract-type and geographic location exclude lease income of $ 17 million and $ 24 million for the three months ended April 4, 2025, and March 29, 2024, respectively.
10
Leidos Holdings, Inc.
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
CONTRACT ASSETS AND LIABILITIES
Performance obligations are satisfied either over time as work progresses or at a point in time. Firm-fixed-price contracts are typically billed to the customer using milestone payments while cost-reimbursable and time and materials contracts are typically billed to the customer on a monthly or bi-weekly basis as indicated by the negotiated billing terms and conditions of the contract. As a result, the timing of revenue recognition, customer billings and cash collections for each contract results in a net contract asset or liability at the end of each reporting period.
Contract assets consist of unbilled receivables, which is the amount of revenue recognized that exceeds the amount billed to the customer. Unbilled receivables exclude amounts billable where the right to consideration is solely subject to the passage of time. Contract liabilities consist of deferred revenue, which represents cash advances received prior to performance for programs and billings in excess of revenue recognized.
The components of contract assets and contract liabilities consisted of the following:
(in millions) Balance sheet line item April 4,
2025 January 3,
2025
Contract assets - current:
Unbilled receivables Receivables, net $ 865 $ 842
Contract liabilities - current:
Deferred revenue (1)
Accounts payable and accrued liabilities $ 368 $ 333
Contract liabilities - non-current:
Deferred revenue (1)
Other long-term liabilities $ 8 $ 10
(1) Certain contracts record revenue net of cost of revenues, and therefore, the respective deferred revenue balance will not fully convert to revenue.
The increase in unbilled receivables was primarily due revenue recognized on certain contracts, partially offset the timing of billings on certain contracts. The increase in deferred revenue was primarily due to the timing of advanced payments from customers, offset by revenue recognized during the period.
For the three months ended April 4, 2025, $ 137 million of revenue recognized was included as a contract liability at January 3, 2025. For the three months ended March 29, 2024, $ 157 million of revenue recognized was included as a contract liability at December 29, 2023.
Note 3–Acquisitions, Goodwill and Intangible Assets
BUSINESS ACQUISITION
On March 10, 2025, we entered into a definitive agreement to acquire a full spectrum cyber company for a preliminary purchase price of $ 300 million, subject to working capital and other customary adjustments. The transaction is expected to be completed in the second quarter of 2025, subject to the satisfaction or waiver of customary closing conditions. The company develops offensive and defensive cyber platforms and other solutions for the U.S. Government.
GOODWILL
The following table presents changes in the carrying amount of goodwill by reportable segment:
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
Goodwill at December 29, 2023 (1)
$ 2,758 $ 1,366 $ 800 $ 1,188 $ 6,112
Foreign currency translation adjustments — — ( 28 ) — ( 28 )
Goodwill at January 3, 2025 (1)
2,758 1,366 772 1,188 6,084
Foreign currency translation adjustments — — 14 — 14
Goodwill at April 4, 2025 (1)
$ 2,758 $ 1,366 $ 786 $ 1,188 $ 6,098
(1) Carrying amount includes accumulated impairment loss of $ 596 million within the Commercial & International segment.
Leidos Holdings, Inc.
11
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
We evaluate qualitative factors that could cause us to consider whether the estimated fair value of each of our reporting units may be lower than the carrying value and trigger a quantitative assessment, including, but not limited to (i) macroeconomic conditions, (ii) industry and market considerations, (iii) our overall financial performance, including an analysis of our current and projected cash flows, revenues and earnings, (iv) a sustained decrease in share price and (v) other relevant entity-specific events including changes in management, strategy, partners or litigation.
During the three months ended April 4, 2025, and March 29, 2024, there were no impairments to goodwill.
INTANGIBLE ASSETS
Intangible assets, net consisted of the following:
April 4, 2025 January 3, 2025
(in millions) Gross carrying value Accumulated amortization Net carrying value Gross carrying value Accumulated amortization Net carrying value
Finite-lived intangible assets:
Programs
$ 1,687 $ ( 1,317 ) $ 370 $ 1,686 $ ( 1,293 ) $ 393
Software and technology
262 ( 171 ) 91 261 ( 165 ) 96
Customer relationships
53 ( 29 ) 24 52 ( 28 ) 24
Total finite-lived intangible assets
2,002 ( 1,517 ) 485 1,999 ( 1,486 ) 513
Indefinite-lived intangible assets:
Trade names 4 — 4 4 — 4
Total intangible assets $ 2,006 $ ( 1,517 ) $ 489 $ 2,003 $ ( 1,486 ) $ 517
Amortization expense was $ 30 million and $ 37 million for the three months ended April 4, 2025, and March 29, 2024, respectively.
Program intangible assets are amortized over their respective estimated useful lives in proportion to the pattern of economic benefit based on expected future discounted cash flows. Customer relationships and software and technology intangible assets are amortized either on a straight-line basis over their estimated useful lives or over their respective estimated useful lives in proportion to the pattern of economic benefit based on expected future discounted cash flows, as deemed appropriate.
The estimated annual amortization expense as of April 4, 2025, was as follows:
Fiscal year ending (in millions)
2025 (remainder of year) $ 90
2026 98
2027 72
2028 62
2029 53
2030 and thereafter 110
$ 485
12
Leidos Holdings, Inc.
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Note 4–Fair Value Measurements
The accounting standard for fair value measurements establishes a three-level fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: observable inputs such as quoted prices in active markets (Level 1); inputs other than quoted prices in active markets that are observable, either directly or indirectly, or quoted prices that are not active (Level 2); and unobservable inputs in which there is little or no market data (e.g., discounted cash flow and other similar pricing models), which requires us to develop our own market participant assumptions used in pricing the asset or liability (Level 3).
The financial instruments measured at fair value on a recurring basis primarily consisted of the following:
April 4, 2025 January 3, 2025
(in millions) Carrying value Fair value Carrying value Fair value
Financial assets:
Derivatives $ 3 $ 3 $ 4 $ 4
As of April 4, 2025, and January 3, 2025, our derivatives primarily consisted of the cash flow interest rate swaps on $ 500 million of the variable rate senior unsecured term loan (see "Note 5–Derivative Instruments"). The fair value of the cash flow interest rate swaps is determined based on observed values for underlying interest rates on the one-month Secured Overnight Financing Rate ("SOFR") rate as of April 4, 2025, and January 3, 2025 (Level 2 inputs).
The carrying amounts of our financial instruments, other than derivatives, which include cash equivalents, accounts receivable, accounts payable and accrued expenses, are reasonable estimates of their related fair values. As of April 4, 2025, and January 3, 2025, the carrying value of our notes receivable of $ 16 million approximates fair value as the stated interest rates within the agreements are consistent with the current market rates for similar instruments (Level 2 inputs). Our notes receivable are included within “Other current assets” and "Other long-term assets" on the condensed consolidated balance sheets.
As of April 4, 2025, and January 3, 2025, the fair value of debt was $ 5.1 billion and $ 4.5 billion, respectively, and the carrying amount was $ 5.1 billion and $ 4.7 billion, respectively (see "Note 6–Debt"). The fair value of long-term debt is determined based on current interest rates available for debt with terms and maturities similar to our existing debt arrangements and our credit rating (Level 2 inputs).
Note 5–Derivative Instruments
We manage our risk to changes in interest rates through the use of derivative instruments. We do not hold derivative instruments for trading or speculative purposes. For variable rate borrowings, we use fixed interest rate swaps, effectively converting a portion of the variable interest rate payments to fixed interest rate payments. These swaps are designated as cash flow hedges.
The fair value of the interest rate swaps was as follows:
(in millions) Balance sheet line item April 4,
2025 January 3,
2025
Cash flow interest rate swaps Other current assets
$ 3 $ 4
The cash flows associated with the interest rate swaps are classified as operating activities in the condensed consolidated statements of cash flows.
Leidos Holdings, Inc.
13
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
CASH FLOW HEDGES
We have interest rate swap agreements to hedge the cash flows of $ 500 million of the variable rate senior unsecured term loan (the "Variable Rate Loan"). These interest rate swap agreements have a maturity date of August 2025 and a fixed interest rate of 2.96 %. The objective of these instruments is to reduce variability in the forecasted interest payments of the Variable Rate Loan. Under the terms of the interest rate swap agreements, we will receive monthly variable interest payments based on the one-month SOFR and will pay interest at a fixed rate.
The interest rate swap transactions are accounted for as cash flow hedges. The gain/loss on the swaps is reported as a component of other comprehensive income (loss) and is reclassified into earnings when the interest payments on the underlying hedged items impact earnings. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.
The effect of the cash flow hedges on other comprehensive income (loss) and earnings for the periods presented was as follows:
Three Months Ended
(in millions) April 4,
2025 March 29,
2024
Total interest expense, net presented in the condensed consolidated statements of operations in which the effects of cash flow hedges are recorded
$ 49 $ 49
Amount recognized in other comprehensive income — 5
Amount reclassified from accumulated other comprehensive loss to interest expense, net ( 1 ) ( 3 )
We expect to reclassify net gains of $ 2 million from accumulated other comprehensive loss into earnings during the next 12 months.
Note 6–Debt
Our debt consisted of the following:
(in millions) Stated interest rate Effective interest rate April 4,
2025 January 3,
2025
Senior unsecured term loan:
$ 1,000 million term loan, due March 2028
5.67 % 5.84 % $ 975 $ 1,000
Senior unsecured notes:
$ 500 million notes, due May 2025
3.63 % 3.76 % — 500
$ 750 million notes, due May 2030
4.38 % 4.50 % 750 750
$ 1,000 million notes, due February 2031
2.30 % 2.38 % 1,000 1,000
$ 500 million notes, due March 2032
5.40 % 5.42 % 500 —
$ 250 million notes, due July 2032
7.13 % 7.43 % 250 250
$ 750 million notes, due March 2033
5.75 % 5.81 % 750 750
$ 300 million notes, due July 2033
5.50 % 5.88 % 161 161
$ 500 million notes, due March 2035
5.50 % 5.55 % 500 —
$ 300 million notes, due December 2040
5.95 % 6.03 % 218 218
Finance leases due on various dates through fiscal 2032 Various 1.84 %- 6.31 %
69 73
Less: unamortized debt discounts and deferred debt issuance costs ( 40 ) ( 32 )
Total long-term debt 5,133 4,670
Less current portion ( 119 ) ( 618 )
Total long-term debt, net of current portion $ 5,014 $ 4,052
14
Leidos Holdings, Inc.
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
REVOLVING CREDIT FACILITY
We have a $ 1.0 billion senior unsecured revolving facility (the “Revolving Facility”). The Revolving Facility will mature in March 2028 and is subject to an annual commitment fee rate of 0.125 % on the unused credit availability and permits two additional one-year extensions subject to lender consent. Principal payments are made quarterly, with the majority of the principal due at maturity. As of April 4, 2025, and January 3, 2025, there were no borrowings outstanding under the Revolving Facility.
SENIOR NOTES
On February 20, 2025, we issued and sold $ 500 million senior notes maturing in March 2032 (the "2032 Notes") and $ 500 million senior notes maturing in March 2035 (the "2035 Notes", and together with the 2032 Notes, the "Notes"). The Notes are senior unsecured obligations issued by Leidos, Inc. and guaranteed by Leidos Holdings, Inc. The annual interest rates for the 2032 Notes and the 2035 Notes are 5.40 % and 5.50 %, respectively, and the interest is payable on a semi-annual basis. In connection with the issuance of the Notes, $ 10 million of debt issuance costs and discount were recognized, which were recorded as an offset against the carrying value of debt. The proceeds from the Notes were used to retire the $ 500 million senior unsecured notes due May 2025 and repurchase $ 500 million outstanding shares of common stock in connection with the Accelerated Share Repurchase ("ASR") agreement (see "Note 8–Earnings Per Share").
COMMERCIAL PAPER
We have a commercial paper program in which the Company may issue short-term unsecured commercial paper notes ("Commercial Paper Notes") not to exceed $ 1.0 billion. The proceeds will be used for general corporate purposes, including working capital, capital expenditures, acquisitions and share repurchases.
The Commercial Paper Notes are issued in minimum denominations of $ 0.25 million and have maturities of up to 397 days from the date of issuance. The Commercial Paper Notes either bear a stated or floating interest rate, if interest bearing, or will be sold at a discount from the face amount. As of April 4, 2025, and January 3, 2025, we did not have any Commercial Paper Notes outstanding.
COVENANTS
The senior unsecured term loan, senior unsecured notes and Revolving Facility are fully and unconditionally guaranteed and contain certain customary restrictive covenants, including among other things, restrictions on our ability to create liens and enter into sale and leaseback transactions under certain circumstances.
The financial covenants in the Revolving Facility and the senior unsecured term loan require that we maintain, as of the last day of each fiscal quarter, a ratio of adjusted consolidated total debt to consolidated EBITDA of not more than 3.75 to 1.00, subject to increases to 4.50 to 1.00 for four fiscal quarters following a material acquisition, and a ratio of EBITDA to consolidated interest expense of not less than 3.50 to 1.00.
We were in compliance with all financial covenants as of April 4, 2025.
PRINCIPAL PAYMENTS
Future minimum payments of debt are as follows:
Fiscal Year Ending (in millions)
2025 (remainder of year) $ 90
2026 120
2027 114
2028 705
2029 5
2030 and thereafter 4,139
Total principal payments 5,173
Less: unamortized debt discount and issuance costs ( 40 )
Total long-term debt $ 5,133
Leidos Holdings, Inc.
15
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Note 7–Accumulated Other Comprehensive Income (Loss)
Changes in the components of Accumulated Other Comprehensive Income (Loss) ("AOCI") were as follows:
(in millions) Foreign currency translation adjustments Unrecognized gain (loss) on derivative instruments Pension adjustments Total AOCI
Balance at December 29, 2023 $ ( 39 ) $ 5 $ ( 14 ) $ ( 48 )
Other comprehensive income (loss) ( 64 ) 5 2 ( 57 )
Taxes 5 2 ( 1 ) 6
Reclassification from AOCI — ( 11 ) — ( 11 )
Balance at January 3, 2025 ( 98 ) 1 ( 13 ) ( 110 )
Other comprehensive income 30 — — 30
Taxes ( 2 ) — — ( 2 )
Reclassification from AOCI — ( 1 ) — ( 1 )
Balance at April 4, 2025 $ ( 70 ) $ — $ ( 13 ) $ ( 83 )
Reclassifications from unrecognized gain (loss) on derivative instruments are recorded in "Interest expense, net" in the condensed consolidated statements of operations.
Note 8–Earnings Per Share
The following table provides a reconciliation of the weighted average number of shares outstanding used to compute basic and diluted EPS for the periods presented:
Three Months Ended
(in millions) April 4,
2025 March 29,
2024
Basic weighted average number of shares outstanding 130 136
Dilutive common share equivalents—stock options and other stock awards
1 1
Diluted weighted average number of shares outstanding 131 137
Anti-dilutive stock-based awards are excluded from the weighted average number of shares outstanding used to compute diluted EPS. The total outstanding stock options and vesting stock awards that were anti-dilutive were less than 0.5 million for the three months ended April 4, 2025, and 1 million for the three months ended March 29, 2024.
On February 20, 2025, we entered into an ASR agreement with a financial institution to repurchase shares of our outstanding common stock. We paid $ 500 million to the financial institution and received an initial delivery of 3 million shares at an average price of $ 131.50 per share. The purchase was recorded to "Additional paid-in capital" in the condensed consolidated balance sheets. All shares delivered were immediately retired. The final number of shares to be repurchased will be based on the company's volume-weighted average share price during the term of the agreement, less a discount. The ASR is expected to be completed in the second quarter of 2025.
During the three months ended March 29, 2024, we made open market repurchases of our common stock for an aggregate purchase price of $ 150 million. All shares repurchased were immediately retired. There were no open market share repurchases during the three months ended April 4, 2025.
Note 9–Income Taxes
For the three months ended April 4, 2025, the effective tax rate was 23.6 % compared to 23.1 % for the three months ended March 29, 2024. The increase to the effective tax rate was primarily due to a decrease in excess tax benefits related to employee stock-based payment transactions.
16
Leidos Holdings, Inc.
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Note 10–Business Segments
Our operations and reportable segments are organized around the customers and markets we serve. We define our reportable segments based on the way the chief operating decision maker ("CODM"), currently our Chief Executive Officer, manages operations for the purposes of allocating resources and assessing performance. The CODM considers segment revenue and operating income to assist with the evaluation of strategic business decisions, including potential acquisitions or divestitures, whether to invest in certain products or services, share repurchases and the declaration of dividends.
The following table summarizes business segment information for the periods presented:
Three Months Ended April 4, 2025
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
Revenues $ 1,878 $ 1,291 $ 568 $ 508 $ 4,245
Less:
Direct labor 503 244 103 109 959
Amortization of intangible assets 5 6 7 12 30
Other segment expense 1,185 742 421 353 2,701
Segment operating income $ 185 $ 299 $ 37 $ 34 $ 555
Corporate expense 25
Total operating income $ 530
Three Months Ended March 29, 2024
(in millions) National Security & Digital Health & Civil Commercial & International Defense Systems Total
Revenues $ 1,793 $ 1,199 $ 509 $ 474 $ 3,975
Less:
Direct labor
479 236 100 101 916
Amortization of intangible assets 6 6 8 17 37
Other segment expense 1,133 735 367 335 2,570
Segment operating income $ 175 $ 222 $ 34 $ 21 $ 452
Corporate expense
37
Total operating income $ 415
The statement of operations performance measures used to evaluate segment performance are revenues and operating income. As a result, "Interest expense, net," "Other (expense) income, net" and "Income tax expense" as reported in the condensed consolidated statements of operations are not allocated to our segments.
Other segment expenses include direct program costs such as material and subcontractor expenses, as well as allocable indirect costs such as depreciation and Corporate compensation expenses, but excludes direct labor which is separately presented above. The Health & Civil and Defense Systems segments also include equity earnings of non-consolidated subsidiaries within operating income.
Under U.S. Government Cost Accounting Standards, indirect costs including depreciation expense are collected in indirect cost pools, which are then collectively allocated to the reportable segments based on a representative causal or beneficial relationship of the costs in the pool to the costs in the base. As such, depreciation expense is not separately disclosed on the condensed consolidated statements of operations.
Asset information by segment is not a key measure of performance used by the CODM.
Leidos Holdings, Inc.
17
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Note 11–Commitments and Contingencies
LEGAL PROCEEDINGS
We are involved in various claims and lawsuits arising in the normal conduct of our business, none of which, in the opinion of management, based upon current information, will likely have a material adverse effect on our financial position, results of operations or cash flows.
CONTINGENCIES
Government Investigations and Reviews
We are routinely subject to investigations and reviews relating to compliance with various laws and regulations with respect to our role as a contractor to federal, state and local government customers and in connection with performing services in countries outside of the United States. Adverse findings could have a material effect on our business, financial position, results of operations and cash flows due to our reliance on government contracts.
Defense Contract Audit Agency
As of April 4, 2025, active indirect cost audits by the Defense Contract Audit Agency remain open for fiscal 2022 and subsequent fiscal years. Although we have recorded contract revenues based upon an estimate of costs that we believe will be approved upon final audit or review, we cannot predict the outcome of any ongoing or future audits or reviews and adjustments, and if future adjustments exceed estimates, our profitability may be adversely affected. As of April 4, 2025, we believe we have adequately reserved for potential adjustments from audits or reviews of contract costs.
Other Government Investigations and Reviews
As previously disclosed, the Company voluntarily self-reported to the Department of Justice and the Securities and Exchange Commission an investigation related to activities by its employees, third party representatives and subcontractors, raising concerns related to a portion of our business that conducts international operations, and has cooperated with both agencies. In December 2024, the Company received notification from the U.S. Department of Justice that it had closed its inquiry. While the Company has engaged with the SEC, the Company cannot anticipate the timing, outcome or possible impact of an SEC investigation, although violations of applicable laws may result in civil sanctions, including monetary penalties, and reputational damage.
In August 2022, the Company received a Federal Grand Jury Subpoena in connection with a criminal investigation being conducted by the U.S. Department of Justice Antitrust Division. The subpoena requests that the Company produce a broad range of documents related to three U.S. Government procurements associated with the Company’s Intelligence Group in 2021 and 2022. We are fully cooperating with the investigation, and we are conducting our own internal investigation with the assistance of outside counsel. It is not possible at this time to determine whether we will incur, or to reasonably estimate the amount of, any fines, penalties, or further liabilities in connection with the investigation pursuant to which the subpoena was issued.
COMMITMENTS
As of April 4, 2025, we have outstanding letters of credit of $ 57 million, principally related to performance guarantees on contracts and outstanding surety bonds with a notional amount of $ 149 million, principally related to performance and subcontractor payment bonds on contracts. The value of the surety bonds may vary due to changes in the underlying project status and/or contractual modifications.
18
Leidos Holdings, Inc.
Table of Contents
LEIDOS HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
As of April 4, 2025, the future expirations of the outstanding letters of credit and surety bonds were as follows:
Fiscal year ending (in millions)
2025 (remainder of year) $ 125
2026 16
2027 42
2028 14
2029 7
2030 and thereafter 2
$ 206
Leidos Holdings, Inc.
19
Table of Contents
PART I—FINANCIAL INFORMATION
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.